Loading...

ELITE PHARMACEUTICALS INC US FDA Inspections 8-K Filing

LT P

ELITE PHARMACEUTICALS INC

()

2025 8-K

Product Launch Announcement

Financial Results Report

Conference Call Announcement

Quarterly Financial Report

Conference Call Update

FDA Approval Granted

Conference Call Announcement

Quarterly Results Update

Financial Statements

Clinical Trials

New Product Launches

Product Shipment

Quarterly Results

External Links:

On June 16, 2025, Elite Pharmaceuticals, Inc. announced positive results from a bioequivalence study for a generic anticoagulant drug, indicating it is equivalent to the branded version, as they prepare to file with the FDA.

AI Assistant

ELITE PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.